This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Longer use of tamoxifen cuts breast cancer deaths
The study shows that extending tamoxifen to 10 years lowers recurrence risk by 25 percent and breast cancer mortality by 29 percent versus five years. Net benefit rises over time, suggesting premenopausal women at high risk should consider longer therapy despite higher adherence demands.
MENTIONED IN THIS ARTICLE
Peter Ravdin
UT Health Science Center
San Antonio
Lancet
Rawdin
United States